Infectious Diseases News and Research

RSS

Discovery provides new mechanism that could be exploited to create malaria vaccine

Scientists have revealed that immune cells called natural killer (NK) cells may play a key role in ridding the body of malaria-infected blood cells, a study in eLife reports.

27 Jun 2018

Targeting proteins in semen could prevent sexually transmitted spread of Ebola virus

Protein fragments, called amyloid fibrils, in human semen significantly increase Ebola virus infection and protect the virus against harsh environmental conditions such as heat and dehydration. Researchers from the Perelman School of Medicine at the University of Pennsylvania report these findings in a study published this week in the Proceedings of the National Academy of Sciences.

26 Jun 2018

Testosterone levels in men largely determined by their childhood environment

Men's testosterone levels are largely determined by their environment during childhood, according to new research.

25 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

LSTM led consortium receives grant to investigate how human behavior impacts AMR

An LSTM led consortium called DRUM has been awarded £3 million to investigate the way in which human behaviour drives the emergence and spread of antimicrobial resistance

22 Jun 2018

UC San Diego launches new bacteriophage therapy center

With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in collaboration with national research institutions and private industry, are leveraging hard-won expertise to exploit a natural viral enemy of pathogenic bacteria, creating North America's first Center for Innovative Phage Applications and Therapeutics

22 Jun 2018

New study reveals how ‘good’ bacteria help in regulating our metabolism

Research tells us that the commensal or "good" bacteria that inhabit our intestines help to regulate our metabolism.

22 Jun 2018

Water-limited landscapes can facilitate disease transmission

In water-limited landscapes sick animals can have increased contact with healthy individuals, which can facilitate disease transmission. Scientists from the German Leibniz Institute for Zoo and Wildlife Research present these findings in the British Ecological Society journal Functional Ecology.

20 Jun 2018

Theoretical models predict how juveniles evolve to be more susceptible than adults to infection

In many species, including humans, the young are often more susceptible to infection than adults, even after accounting for prior exposure to infection.

20 Jun 2018

Scientists develop novel computational framework to support personalized cancer treatment

Researchers at Columbia University Irving Medical Center have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.

19 Jun 2018

Novel app teaches users how to stop life-threatening bleeding and save lives

Knowing what to do to save a life in the aftermath of a mass trauma event -- natural disaster, vehicle accident, or violent attack – is now right at the touch of a button.

18 Jun 2018

NIAID launches clinical trial of investigational RSV vaccine

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial virus.

14 Jun 2018

Study: Allergen in red meat linked to plaque buildup in arteries of the heart

A team of researchers says it has linked sensitivity to an allergen in red meat to the buildup of plaque in the arteries of the heart.

14 Jun 2018

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

InDevR Inc. announced product release of the first ever commercial reagent kit designed explicitly for assessment of neuraminidase in influenza vaccines.

12 Jun 2018

Researchers develop spider silk microcapsules that can deliver vaccine directly to immune cells

To fight cancer, researchers increasingly use vaccines that stimulate the immune system to identify and destroy tumor cells.

12 Jun 2018

IU researchers observe bacteria's 'DNA uptake' process

Indiana University scientists have made the first direct observation of a key step in the process that bacteria use to rapidly evolve new traits, including antibiotic resistance.

12 Jun 2018

Translate Bio collaborates with Sanofi to develop mRNA vaccines for infectious diseases

Translate Bio, a clinical-stage messenger RNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction, announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur, the vaccines global business unit of Sanofi, to develop mRNA vaccines for up to five undisclosed infectious disease pathogens.

11 Jun 2018

Researchers isolate bacteria that pose triple threat from a patient in the U.S.

Researchers from the Emory Antibiotic Resistance Center describe the first strain of carbapenem-resistant, hypermucoviscous Klebsiella pneumoniae exhibiting colistin heteroresistance and enhanced virulence isolated from a patient in the United States.

11 Jun 2018

EMA grants PRIME designation to Themis' chikungunya vaccine candidate

Themis announced today that the European Medicines Agency has granted PRIority MEdicines designation to its most advanced program in development, a vaccine to prevent chikungunya fever.

11 Jun 2018

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Researchers from GeoVax have developed a flexible "Plug and Play" technology platform that delivers single-dose vaccines that fully protect against emerging infectious diseases such as Zika, Lassa fever, and Ebola.

11 Jun 2018

Infectious Diseases News and Research

Discovery provides new mechanism that could be exploited to create malaria vaccine

Targeting proteins in semen could prevent sexually transmitted spread of Ebola virus

Testosterone levels in men largely determined by their childhood environment

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

LSTM led consortium receives grant to investigate how human behavior impacts AMR

UC San Diego launches new bacteriophage therapy center

New study reveals how ‘good’ bacteria help in regulating our metabolism

Water-limited landscapes can facilitate disease transmission

Theoretical models predict how juveniles evolve to be more susceptible than adults to infection

Scientists develop novel computational framework to support personalized cancer treatment

Novel app teaches users how to stop life-threatening bleeding and save lives

NIAID launches clinical trial of investigational RSV vaccine

Study: Allergen in red meat linked to plaque buildup in arteries of the heart

InDevR releases first reagent kit for assessing neuraminidase in influenza vaccines

Researchers develop spider silk microcapsules that can deliver vaccine directly to immune cells

IU researchers observe bacteria's 'DNA uptake' process

Translate Bio collaborates with Sanofi to develop mRNA vaccines for infectious diseases

Researchers isolate bacteria that pose triple threat from a patient in the U.S.

EMA grants PRIME designation to Themis' chikungunya vaccine candidate

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News